0001562180-19-000192.txt : 20190104
0001562180-19-000192.hdr.sgml : 20190104
20190104160234
ACCESSION NUMBER: 0001562180-19-000192
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190102
FILED AS OF DATE: 20190104
DATE AS OF CHANGE: 20190104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CRANDELL KEITH
CENTRAL INDEX KEY: 0001219039
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38319
FILM NUMBER: 19509962
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quanterix Corp
CENTRAL INDEX KEY: 0001503274
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 208957988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 113 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-301-9400
MAIL ADDRESS:
STREET 1: 113 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-01-02
false
0001503274
Quanterix Corp
QTRX
0001219039
CRANDELL KEITH
8755 WEST HIGGINS ROAD, SUITE 1025
CHICAGO
IL
60631
true
false
true
false
Common Stock
2019-01-02
4
A
false
2270.00
0.00
A
4540.00
D
Common Stock
2412001.00
I
Held by ARCH Venture Fund VI, L.P.
Common Stock
1537684.00
I
Held by ARCH Venture Fund VIII Overage, L.P.
Stock Option (Right to Buy)
18.24
2019-01-02
4
A
false
7900.00
0.00
A
2019-12-31
2029-01-02
Common Stock
7900.00
7900.00
D
Represents restricted stock units that vest as to 100% of the shares on December 31, 2019 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
Includes 2,270 restricted stock units.
The shares are held of record by ARCH Venture Fund VI, L.P. ("ARCH Fund VI"). The sole general partner of ARCH Fund VI is ARCH Venture Partners VI, L.P. ("ARCH Partners VI"), which may be deemed to beneficially own the shares held by ARCH Fund VI. The sole general partner of ARCH Partners VI is ARCH Venture Partners VI, LLC ("ARCH VI LLC"), which may be deemed to beneficially own the shares held by ARCH Fund VI. ARCH Partners VI and ARCH VI LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein. As a managing director of ARCH VI LLC, the Reporting Person may be deemed to beneficially own the shares held by ARCH Fund VI. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
The shares are held of record by ARCH Venture Fund VIII Overage, L.P. ("ARCH Fund Overage"). The sole general partner of ARCH Fund Overage is ARCH Venture Partners VIII, LLC ("ARCH VIII LLC"), which may be deemed to beneficially own the shares held by ARCH Fund Overage. ARCH VIII LLC disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. As a managing director of ARCH VIII LLC, the Reporting Person may be deemed to beneficially own the shares held by ARCH Fund Overage. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy.
/s/ Brian Keane, as Attorney-in-Fact for Keith L. Crandell
2019-01-04